A new assay to measure levels of the frataxin protein in blood could be used to assess the effectiveness of…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Motion-capture suits can be combined with machine learning to predict how Friedreich’s ataxia (FA) will progress, a new proof-of-concept…
Abnormalities in the light-sensing cells of the eyes are detectable in carriers of Friedreich’s ataxia (FA), but do not…
Objective measures of eye movement abnormalities are associated with measures of disease severity in Friedriech’s ataxia (FA) and other…
Among people with Friedreich’s ataxia, thinner layers of nerve cells at the retina — the light-sensing cells located at…
Researchers have developed statistical models to help predict the progression of Friedreich’s ataxia using data such as age at…
People with Friedreich’s ataxia show marked abnormalities in the structure of the upper spinal cord, some of which are…
AÂ $4.8 million grant from the California Institute for Regenerative Medicine (CIRM) will support a research project hoping to move a…
In a reversal, the U.S. Food and Drug Administration (FDA) has informed Reata Pharmaceuticals that it will not hold an…
A mutation in the gene SIRT6 is associated with less severe neurological symptoms and visual impairment among people with…